OpenCompanies

Cambridge Antibody Technology Group Limited

Company number
03234033
Status
Active
Type
Private Limited Company
Incorporated
5 Aug 1996
Nature of business
Other research and experimental development on natural sciences and engineering
Corporate group
GMV Nominees Ltd (48216 companies)

Registered office

1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge
CB2 0AA

Previous names

  • Cambridge Antibody Technology Group PLC (until 1 Sep 2011)
  • Intercede 1186 Limited (until 22 Aug 1996)

Officers

NameRoleAppointedResigned
TATTERSALL, Hannah Victoria Director 1 May 2025
BOWDEN, Matthew Shaun Director 27 Feb 2019
COLLINS, Iain Alistair Director 31 May 2017

Control

NameNature of controlNotifiedCeased
Astrazeneca Treasury Limited Ownership Of Shares 75 To 100 Percent
Right To Appoint And Remove Directors		 6 Apr 2016

Accounts

Year ended
31 Dec 2025
31 Dec 2024
31 Dec 2023
31 Dec 2022
31 Dec 2021
31 Dec 2020
31 Dec 2019
31 Dec 2018
31 Dec 2017
31 Dec 2016
31 Dec 2015
31 Dec 2014
31 Dec 2013
31 Dec 2012
31 Dec 2011
31 Dec 2010
31 Dec 2009
31 Dec 2008
31 Dec 2007
31 Dec 2006
30 Sep 2005
30 Sep 2004
30 Sep 2003
30 Sep 2002
30 Sep 2001
30 Sep 2000
30 Sep 1999
30 Sep 1998
30 Sep 1997

Connections

Owned by

Cambridge Antibody Technology Group Limited → Astrazeneca Treasury Limited → Astrazeneca UK Limited → Astrazeneca Intermediate Holdings Limited → Astrazeneca PLC

Controls

Directors’ other companies

Companies at the same address

Data